FDA grants accelerated approval to adagrasib for KRAS G12C-mutated NSCLCC SchlattDec 14, 20221 min readUpdated: Dec 16, 2022December 12, 2022https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-adagrasib-kras-g12c-mutated-nsclc
